Editor: What To Know
- Micro-Tech Endoscopy and Interscope inked a partnership agreement to collaborate and distribute the EndoRotor System for interventional gastroenterology.
- Our innovative product, paired with the driving force of Micro-Tech, will dramatically accelerate physician access to the EndoRotor and the benefits it provides,”.
- “We want to thank the hospitals, clinicians, and staff who were involved in our recent clinical trial, as well as those who contributed to our real-world data collection.
December 30, 2020
Micro-Tech Endoscopy and Interscope inked a partnership agreement to collaborate and distribute the EndoRotor System for interventional gastroenterology.
“Micro-Tech’s position as a market disruptor with strong leadership provides significant scale to the Interscope team. Our innovative product, paired with the driving force of Micro-Tech, will dramatically accelerate physician access to the EndoRotor and the benefits it provides,” explains Jeffery Ryan, Co-Founder, President, and CEO of Interscope, Inc.
“Our shared drive to deliver innovation to customers brought Micro-Tech Endoscopy and Interscope together,” says Chris Li, President of Micro-Tech Endoscopy USA. “We are extremely excited about this partnership and the benefits it brings to patients.”
This extended clearance makes the EndoRotor the first FDA-cleared device used in DEN for WOPN/WON. “We want to thank the hospitals, clinicians, and staff who were involved in our recent clinical trial, as well as those who contributed to our real-world data collection. Without your efforts, this clearance and clinical validation would not have been possible!” adds Ryan.
